🔎 Trials Near Me

መነሻ › Multiple Myeloma › ዲስትሪክት ኦፍ ኮሎምቢያ › Washington

በWashington፣ DC ለMultiple Myeloma የሚደረጉ ክሊኒካዊ ጥናቶች

ለMultiple Myeloma የሚደረጉ 22 ጥናቶች በWashington እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06904066

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Washington D.C.
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07391657

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT02682667

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
እድሜ ከ18 እስከ 72 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT03412877

Tissue Collection for Studies of Lymph Cancer

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT01676805

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

ተሳታዮችን በመፈለግ ላይደረጃ 4
  • American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07609940

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Center for Cancer and Blood Disorders, Bethesda · 7 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05552222

18F-Fluciclovine PET/CT in Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06103838

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07648264

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Lombardi Comprehensive Cancer Center, Washington D.C.
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT04661137

Collection of Tissue Samples for Cancer Research

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
2 Months · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT00900198

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Georgetown University Medical Center, Washington D.C.
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06615479

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • MedStar Washington Hospital Center MedStar Georgetown Cancer Institute, Washington D.C.
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT07555938

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • GSK Investigational Site, Bethesda · 7 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT07227311

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Sibley Memorial Hospital, Washington D.C.
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT04566328

Mosaic Trial for Stem Cell Transplant Recipients

ተሳታዮችን በመፈለግ ላይ
  • Georgetown University School of Medicine, Washington D.C.
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT06960993

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Maryland Oncology Hematology - Silver Spring /ID# 268562, Silver Spring · 7 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ጁላይ 2026 · NCT05650632

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • The Center for Cancer and Blood Disorders (CCBD), Bethesda · 7 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁን 2026 · NCT04068597

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Sibley Memorial Hospital, Washington D.C.
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ጁን 2026 · NCT05243797

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • Cancer Support Community Research & Training Institute, Washington D.C.
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ኤፕሪ 2026 · NCT02333604

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Washington D.C.
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ኤፕሪ 2026 · NCT06679101

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ማርች 2026 · NCT04988555

በሌሎች ከተሞች ለMultiple Myeloma የሚደረጉ ጥናቶች

በWashington ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።